Active constituents
The
kava-lactones, sometimes referred to as kava-pyrones,
are the most important active constituents in kava
extracts. High-quality kava rhizome contains 5.5–8.3%
kava-lactones. Medicinal extracts used in Europe contain
30–70% kava-lactones. Kava-lactones are thought to have
anti-anxiety, mild analgesic (pain-relieving),
muscle-relaxing, and anticonvulsant effects. Some
researchers speculate that kava may directly influence
the limbic system, the ancient part of the brain
associated with emotions and other brain
activities.4 Kava is a unique anti-anxiety
alternative because it does not seem to impair reaction
time or alertness when used in the amounts recommended
below.
Kava
has been extensively studied as a treatment for anxiety.
The amount often used in clinical trials is 100 mg of an
extract (standardized to 70% kava-lactones) three times
per day. Double-blind trials, including one that lasted
six months, have shown that kava effectively reduces
symptoms of anxiety in people with mild to moderate
anxiety. One trial found that kava also reduced symptoms
of anxiety in menopausal women, and in another study
kava enhanced the anti-anxiety effect of hormone
replacement therapy. One trial found
kava to be just as effective as benzodiazepines (a
common class of drugs prescribed for anxiety) in
treating mild anxiety over the course of six
weeks.
Are there any side effects or
interactions?
In
November 2001, German authorities announced that 24
cases of liver disease (including hepatitis, liver
failure, and cirrhosis) associated with the use of kava
had been reported in Germany; of these, one person died
and three required a liver
transplant.14
Prior to
this report, it had been widely believed that kava did
not cause any serious side effects. The 1998 edition of
the German Commission E Monographs, considered
to be an authoritative source on herbal medicines, does
not mention liver disease in its discussion of kava’s
side effects. Since that time, four case reports of
kava-related liver toxicity have appeared in medical
journals. In two of these cases, severe liver failure
resulted in the need for a liver transplant. Most,
though not all, of the individuals who developed liver
damage while taking kava were also taking at least one
other medication that has been associated with liver
injury. That raises the possibility that these other
drugs, rather than kava, may have been responsible for
the problem in some cases. It is also conceivable that
kava interacts with some of these drugs, thereby
increasing their toxicity. However, some of the cases of
kava-related liver disease cannot be explained by the
concomitant use of other drugs.
The
possibility that kava can cause liver damage is
supported by a survey of an Aboriginal community in
Australia. Although occasional users of kava in this
community generally had normal liver function,
laboratory evidence of liver injury was quite common
among heavy users of the herb. Furthermore, the risk of
liver damage was directly related to the amount of kava
consumed. It is not clear how relevant these findings
are to other communities, since the overall health of
the Aborigines who were studied was relatively
poor.
It is also
unclear whether kava is safe when taken in “normal”
amounts. A recent survey of 400 German medical practices
revealed that 78% of the kava prescriptions that were
written significantly exceeded the recommended amount.
However, some of the 24 patients reported to German
authorities were not exceeding the manufacturer’s
recommended level of intake when they developed liver
disease. In addition, in two of the four published case
reports, the amount of kava used was equal to or only
slightly higher than the manufacturer’s recommendation.
Therefore, one cannot assume that the recommended level
of intake of kava is safe for all
individuals.
Health
authorities worldwide are considering or implementing a
ban on kava. Until additional information clarifies the
extent of the risk involved, it is strongly recommended
that all individuals consult their physician before
taking kava. In addition, based on the available
information, it seems that people with liver disease and
those taking medications that have the potential to
damage the liver should not take
kava.
In
recommended amounts, the most common side effect from
kava use is mild gastrointestinal disturbances in some
people. Kava may temporarily turn the skin yellow,
according to some case studies. If this occurs, people
should discontinue kava use. In rare cases, an allergic
skin reaction, such as a rash, may occur. Enlargement of
the pupils has also been reported after long-term use of
kava. In the amounts discussed above, kava does not
appear to be addictive.
Kava is not
recommended for use by pregnant or breast-feeding women.
It should not be taken together with other substances
that also act on the central nervous system, such as
alcohol, barbiturates, antidepressants, and
antipsychotic drugs. One study found that large amounts
of a traditional kava preparation did worsen cognitive
impairment caused by alcohol consumption. However, at
the amounts recommended above, kava does not appear to
impair cognitive performance. Kava has also been
reported to cause excessive sedation and grogginess when
combined with benzodiazepines. One study found it was
safe to drive after taking kava at the amounts listed
above. However, the German Commission E monograph states
that kava, when taken at the recommended levels, may
adversely affect a person’s ability to safely drive or
operate heavy machinery.
Caution: Aside from the reported
interactions, kava inhibits a number of the cytochrome
P450 enzymes that play a role in the breakdown of many
medications. Therefore, kava has the potential to
interact with a wide range of medications, even if such
interactions have not yet been reported. Individuals
taking any medication who wish to use kava should check
with their physician or pharmacist to determine whether
inhibiting cytochrome P450 could cause an adverse drug
interaction.
Are there any drug
interactions?
Certain medicines may interact
with
kava.